Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Conjugated oestrogens 625microgram tablets
0604011P0AAABAB
|
Oestro Conj (Systemic) | Oestrogens conjugated | Endocrine System | 6,787 |
|
Conjugated oestrogens 1.25mg tablets
0604011P0AAACAC
|
Oestro Conj (Systemic) | Oestrogens conjugated | Endocrine System | 3,836 |
|
Conjugated oestrogens 300microgram tablets
0604011P0AAAFAF
|
Oestro Conj (Systemic) | Oestrogens conjugated | Endocrine System | 1,888 |
|
Conjugated oestrogens 2.5mg tablets
0604011P0AAADAD
|
Oestro Conj (Systemic) | Oestrogens conjugated | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.